"Sepazon" redirects here. Not to be confused with Sibazon, a brand name for
diazepam in Russia.
Cloxazolam |
 |
|
| Trade names | Akton, Cloxam, Clozal, Elum, Olcadil, and Sepazon[1] |
|---|
| AHFS/Drugs.com | International Drug Names |
|---|
Routes of administration | Oral |
|---|
| ATC code | |
|---|
|
| Legal status |
- BR: Class B1 (Psychoactive drugs)[2]
- CA: Schedule IV
- DE: Anlage III (Special prescription form required)
- UK: Class C
- US: Schedule IV
|
|---|
|
| Metabolism | Hepatic |
|---|
| Elimination half-life | 65 hours |
|---|
| Excretion | Renal |
|---|
|
10-chloro-11b-(2-chlorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| DrugBank | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| KEGG | |
|---|
| ChEMBL | |
|---|
| CompTox Dashboard (EPA) | |
|---|
|
| Formula | C17H14Cl2N2O2 |
|---|
| Molar mass | 349.21 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
Clc1ccccc1C42OCCN2CC(=O)Nc3c4cc(Cl)cc3
|
InChI=1S/C17H14Cl2N2O2/c18-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)19)21(7-8-23-17)10-16(22)20-15/h1-6,9H,7-8,10H2,(H,20,22) YKey:ZIXNZOBDFKSQTC-UHFFFAOYSA-N Y
|
N Y (what is this?) (verify) |
Cloxazolam is a benzodiazepine derivative that has anxiolytic, sedative, and anticonvulsant properties.[3][4] It is not widely used;[3] as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan.[1] In 2019, it has been retired from the Belgian market.[5]
See also
References
External links
Anxiolytics (N05B) |
|---|
| 5-HT1ARTooltip 5-HT1A receptor agonists | |
|---|
| GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators | |
|---|
Gabapentinoids (α2δ VDCC blockers) | |
|---|
| Antidepressants |
- SSRIsTooltip Selective serotonin reuptake inhibitors (e.g., escitalopram)
- SNRIsTooltip Serotonin-norepinephrine reuptake inhibitors (e.g., duloxetine)
- SARIsTooltip Serotonin antagonist and reuptake inhibitors (e.g., trazodone)
- TCAsTooltip Tricyclic antidepressants (e.g., clomipramine#)
- TeCAsTooltip Tetracyclic antidepressants (e.g., mirtazapine)
- MAOIsTooltip Monoamine oxidase inhibitors (e.g., phenelzine); Others: Agomelatine
- Bupropion
- Tianeptine
- Vilazodone
- Vortioxetine
|
|---|
Sympatholytics (Antiadrenergics) |
- Alpha-1 blockers (e.g., prazosin)
- Alpha-2 agonists (e.g., clonidine, dexmedetomidine, guanfacine)
- Beta blockers (e.g., propranolol, atenolol, betaxolol, nadolol, oxprenolol, pindolol)
|
|---|
| Others | |
|---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
Benzodiazepines |
|---|
| 1,4-Benzodiazepines | |
|---|
| 1,5-Benzodiazepines |
- Arfendazam
- Clobazam
- CP-1414S
- Lofendazam
- Triflubazam
|
|---|
| 2,3-Benzodiazepines* |
- Girisopam
- GYKI-52466
- GYKI-52895
- Nerisopam
- Talampanel
- Tofisopam
|
|---|
| Triazolobenzodiazepines |
- Adinazolam
- Alprazolam
- Balovaptan*
- Bromazolam
- Clonazolam
- Estazolam
- Fluadinazolam
- Flualprazolam
- Flubromazolam
- Flunitrazolam
- Nitrazolam
- Phenazolam
- Pyrazolam
- Rilmazolam (active metabolite of Rilmazafone)
- Triazolam
|
|---|
| Imidazobenzodiazepines |
- Bretazenil
- Climazolam
- EVT-201
- FG-8205
- Flumazenil
- GL-II-73
- Imidazenil
- 123I-Iomazenil
- L-655,708
- Loprazolam
- Midazolam
- PWZ-029
- Remimazolam
- Ro15-4513
- Ro48-6791
- Ro48-8684
- Ro4938581
- Sarmazenil
- SH-053-R-CH3-2′F
|
|---|
| Oxazolobenzodiazepines | |
|---|
| Thienodiazepines | |
|---|
| Thienotriazolodiazepines |
- α-Hydroxyetizolam
- Apafant*
- Brotizolam
- Ciclotizolam
- Clotizolam
- Deschloroclotizolam
- Deschloroetizolam
- Etizolam
- Flubrotizolam
- Fluclotizolam
- Fluetizolam
- Israpafant*
- JQ1*
- Metizolam
|
|---|
| Thienobenzodiazepines* | |
|---|
| Pyridodiazepines | |
|---|
| Pyridotriazolodiazepines | |
|---|
| Pyrazolodiazepines |
- Razobazam*
- Ripazepam
- Zolazepam
- Zomebazam
- Zometapine*
|
|---|
| Pyrrolodiazepines | |
|---|
| Tetrahydroisoquinobenzodiazepines | |
|---|
| Pyrrolobenzodiazepines* | |
|---|
| Benzodiazepine prodrugs |
- Alprazolam triazolobenzophenone
- Avizafone
- Rilmazafone
|
|---|
* atypical activity profile (not GABAA receptor ligands) |
GABAA receptor positive modulators |
|---|
| Alcohols | |
|---|
| Barbiturates | |
|---|
| Benzodiazepines | |
|---|
| Carbamates |
- Carisbamate
- Carisoprodol
- Clocental
- Cyclarbamate
- Difebarbamate
- Emylcamate
- Ethinamate
- Febarbamate
- Felbamate
- Hexapropymate
- Hydroxyphenamate
- Lorbamate
- Mebutamate
- Meprobamate
- Nisobamate
- Pentabamate
- Phenprobamate
- Procymate
- Styramate
- Tetrabamate
- Tybamate
|
|---|
| Flavonoids | |
|---|
| Imidazoles |
- Etomidate
- Metomidate
- Methoxyetomidate
- Propoxate
- Isopropoxate
- Butomidate
- Iso-butomidate
- Sec-butomidate
- CF2-Etomidate
- CF3-Etomidate
- CF3-Propoxate
- Flutomidate
- 2,6-Dichloro-3-fluoroetomidate
|
|---|
| Kava constituents |
- 10-Methoxyyangonin
- 11-Methoxyyangonin
- 11-Hydroxyyangonin
- Desmethoxyyangonin
- 11-Methoxy-12-hydroxydehydrokavain
- 7,8-Dihydroyangonin
- Kavain
- 5-Hydroxykavain
- 5,6-Dihydroyangonin
- 7,8-Dihydrokavain
- 5,6,7,8-Tetrahydroyangonin
- 5,6-Dehydromethysticin
- Methysticin
- 7,8-Dihydromethysticin
- Yangonin
|
|---|
| Monoureides |
- Acecarbromal
- Apronal (apronalide)
- Bromisoval
- Carbromal
- Capuride
- Ectylurea
|
|---|
| Neuroactive steroids | |
|---|
| Nonbenzodiazepines |
- Imidazopyridines: Alpidem
- DS-1
- Necopidem
- Saripidem
- Zolpidem
- Pyrazolopyrimidines: Divaplon
- Fasiplon
- Indiplon
- Lorediplon
- Ocinaplon
- Panadiplon
- Taniplon
- Zaleplon
- Others: Adipiplon
- AXS-17 (BAER-101, AZD-7325)
- CGS-8216
- CGS-9896
- CGS-13767
- CGS-20625
- CL-218,872
- CP-615,003
- CTP-354
- ELB-139
- GBLD-345
- Imepitoin
- JM-1232
- L-838,417
- Lirequinil (Ro41-3696)
- Miltirone (rosmariquinone)
- NS-2664
- NS-2710
- NS-11394
- Pipequaline
- ROD-188
- RWJ-51204
- SB-205,384
- SX-3228
- TGSC01AA
- TP-003
- TPA-023
- TP-13
- U-89843A
- U-90042
- Viqualine
- Y-23684
|
|---|
| Phenols | |
|---|
| Piperidinediones | |
|---|
| Pyrazolopyridines |
- Cartazolate
- Etazolate
- ICI-190,622
- Tracazolate
|
|---|
| Quinazolinones |
- Afloqualone
- Cloroqualone
- Diproqualone
- Etaqualone
- Mebroqualone
- Mecloqualone
- Methaqualone
- Methylmethaqualone
- Nitromethaqualone
- SL-164
|
|---|
| Volatiles/gases | |
|---|
| Others/unsorted |
- 3-Hydroxybutanal
- α-EMTBL
- AA-29504
- Alogabat
- Avermectins (e.g., ivermectin)
- Bromide compounds (e.g., lithium bromide, potassium bromide, sodium bromide)
- Carbamazepine
- Chloralose
- Chlormezanone
- Clomethiazole
- Darigabat
- DEABL
- Deuterated etifoxine
- Dihydroergolines (e.g., dihydroergocryptine, dihydroergosine, dihydroergotamine, ergoloid (dihydroergotoxine))
- DS2
- Efavirenz
- Etazepine
- Etifoxine
- Fenamates (e.g., flufenamic acid, mefenamic acid, niflumic acid, tolfenamic acid)
- Fluoxetine
- Flupirtine
- Hopantenic acid
- KRM-II-81
- Lanthanum
- Lavender oil
- Lignans (e.g., 4-O-methylhonokiol, honokiol, magnolol, obovatol)
- Loreclezole
- Menthyl isovalerate (validolum)
- Monastrol
- Nicotinic acid
- Nicotinamide
- Org 25,435
- Phenytoin
- Propanidid
- Retigabine (ezogabine)
- Safranal
- Seproxetine
- Stiripentol
- Sulfonylalkanes (e.g., sulfonmethane (sulfonal), tetronal, trional)
- Terpenoids (e.g., borneol)
- Topiramate
- Valerian constituents (e.g., isovaleric acid, isovaleramide, valerenic acid, valerenol)
- Unsorted benzodiazepine site positive modulators: α-Pinene
- MRK-409 (MK-0343)
- TCS-1105
- TCS-1205
|
|---|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |